ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 73 filers reported holding ALDEYRA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $84,000 | -20.8% | 14,516 | -18.1% | 0.00% | 0.0% |
| Q2 2019 | $106,000 | -73.6% | 17,722 | -60.2% | 0.00% | -77.8% |
| Q1 2019 | $402,000 | -17.8% | 44,529 | -24.5% | 0.01% | -30.8% |
| Q4 2018 | $489,000 | -52.4% | 58,963 | -21.8% | 0.01% | -38.1% |
| Q3 2018 | $1,027,000 | +396.1% | 75,446 | +194.1% | 0.02% | +425.0% |
| Q2 2018 | $207,000 | +117.9% | 25,655 | +79.6% | 0.00% | +100.0% |
| Q4 2017 | $95,000 | – | 14,287 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
| Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
| Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
| Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
| Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
| Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
| Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
| ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
| Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
| APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |